AGP Picks
View all

The MarCom Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The MarCom Journal.

Press releases published on October 12, 2026

Somantra's study of 34,279 ChatGPT Queries related to General Insurance  Finds Ads Cluster Around Shopping Questions
As Chronic Absenteeism Persists, Schoolio Launches Subject Mastery to Help K–8 Students Keep Up and Catch Up
Five Advertisers show up in 57% of ChatGPT's Ads in insurance queries;  Two of Them Are a Form Builder and a PDF Tool
Venustas Named Exclusive Prize Sponsor of the 'Map the Warmth Giveaway' for Raynaud’s Awareness Month
Mark J. Semeraro Selected to 2027 New Jersey Super Lawyers List for Second Consecutive Year
Five Former National Leaders Honour Tai Ji Men’s Holistic Education and Culture of Conscience in Toronto
ATK Phantom Highlights the Evolution of High-Performance Gaming Mice
Levoit Singapore Marks Conclusion of “Home for Paws, Air for All" Campaign with S$18,000 Donation to SPCA Singapore
Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Granted FDA Fast Track Designation for First-Line Advanced or Metastatic Biliary Tract Cancer
FTK 最終截止日期:業內領先的投資者權益律師事務所 ROSEN 鼓勵 Flotek Industries, Inc. 投資者在對 FTK 提出證券集體訴訟的重要截止日期之前聘請律師
FTK FINAL DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Flotek Industries, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FTK
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Duolingo, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DUOL
全球知名的法律事務所 ROSEN 鼓勵 Duolingo, Inc. 投資人於證券集體訴訟的重要截止日前儘速聘請法律代理 — DUOL
September 2026 Quarterly Results Conference Call
InnoCare Announces Approval of Clinical Trial of Bispecific Antibody ICP-B161 Targeting TL1A and IL-23p19 in China

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The MarCom Journal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.